Thermo Fisher Scientific (TMO) EBITDA (2008 - 2026)
Thermo Fisher Scientific (TMO) EBITDA from Jun 28, 2008 to Mar 28, 2026. The TTM Thermo Fisher Scientific (TMO) EBITDA is $8.97B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Thermo Fisher Scientific (TMO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +29.11% |
| 3 Years TTM | +5.35% |
| 5 Years TTM | +8.19% |
| 10 Years TTM | +13.39% |
| All Time TTM | +15.74% |
Annual EBITDA change of Thermo Fisher Scientific (TMO)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $2.17B | -75.34% |
| 2025 | $8.80B | +3.57% |
| 2024 | $8.49B | +7.14% |
| 2023 | $7.93B | -15.48% |
| 2022 | $9.38B | -13.63% |
| 2021 | $11B | +28.48% |
| 2020 | $8.45B | +63.86% |
| 2019 | $5.16B | -14.74% |
| 2018 | $6.05B | +21.17% |
| 2017 | $4.99B | +18.43% |
| 2016 | $4.22B | +4.77% |
| 2015 | $4.02B | -3.91% |
| 2014 | $4.19B | +60.48% |
| 2013 | $2.61B | +5.83% |
| 2012 | $2.47B | +16.93% |
| 2011 | $2.11B | +3.63% |
| 2010 | $2.03B | +10.82% |
| 2009 | $1.84B | -9.19% |
| 2008 | $2.02B | +16.80% |
| 2007 | $1.73B | N/A |
Comparison Thermo Fisher Scientific (TMO) five years EBITDA CAGR with competitors
Thermo Fisher Scientific (TMO) five years EBITDA CAGR is -3.36%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | -2278.52% |
| MEDP | Medpace Holdings Inc | 25.16% | -849.29% |
| ISPC | iSpecimen Inc | 25.14% | -848.64% |
| PSNL | Personalis Inc | 18.83% | -660.69% |
| WAT | Waters Corp | 17.45% | -619.79% |
| BNR | Burning Rock Biotech Ltd | 17.26% | -614.06% |
| ICLR | Icon Plc | 12.53% | -473.22% |
| IDXX | Idexx Laboratories Inc | 11.66% | -447.34% |
| CSTL | Castle Biosciences Inc | 10.29% | -406.37% |
| MTD | Mettler-Toledo International Inc | 9.87% | -393.86% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -392.45% |
| IQV | IQVIA Holdings Inc | 9.14% | -372.29% |
| RDNT | Radnet Inc | 8.38% | -349.71% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -326.80% |
| ILMN | Illumina Inc | 5.98% | -278.17% |
| A | Agilent Technologies Inc | 5.87% | -274.70% |
| GH | Guardant Health Inc | 5.67% | -268.88% |
| NTRA | Natera Inc | 3.35% | -199.80% |
| TWST | Twist Bioscience Corp | 2.84% | -184.55% |
| BDSX | Biodesix Inc | 2.43% | -172.49% |
| SHC | Sotera Health Company | 2.32% | -169.13% |
| QGEN | Qiagen NV | 2.21% | -165.67% |